MUAD MAYA, MD
Nephrology Physician in JEFFERSONVILLE, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MUAD MAYA, MD reported a CMS MIPS final score of 12.039/100 — below the 83.1 national average — and filed 1,072 Medicare Part D claims in 2023.
- 12.039/100
- MIPS score · -71 vs avg
- 1K
- Part D claims, 2023
- 90%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MUAD MAYA, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
12 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MUAD MAYA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MUAD MAYA, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Nephrology Physician compares to other specialties among Indiana providers
Nephrology Physician share within Indiana
Nephrology Physician is one of the more visible NUCC categories in Indiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MUAD MAYA, MD's 2023 MIPS final score plotted against the Nephrology Physician national average
- MIPS Final Score
- 12.039/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Nephrology Physician) — 12.039/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Nephrology Physician US NPIs
12.039/100 MIPS final score — 71.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Nephrology Physician. Quality dim: 0. Cost dim: 40.13.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MUAD MAYA, MD appears in the CMS NPPES registry as a Nephrology Physician provider holding MD credentials at 1035 WALL ST STE 103, JEFFERSONVILLE, IN, 47130, with a listed phone of (812) 283-9111. NPI 1558322172 was issued on 03/31/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAYA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,072 prescription claims written by this provider, covering 217 Medicare beneficiaries and totaling roughly $58K in drug spend, split 10% brand-name and 90% generic by claim count, with an opioid prescribing rate of 2.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 12.039/100 for the 2023 performance year (Quality 0, Cost 40.13), compared with the national average of 83.1.
Nephrology Physician is a mid-sized specialty nationwide, with 10,534 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1558322172 |
|---|---|
| Specialty | Nephrology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/31/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MUAD MAYA, MD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MUAD MAYA, MD. Source: openpaymentsdata.cms.gov.
Total received
$152
Largest payer
Travere Therapeutics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
10% brand-name claims vs 90% generic, on 1,072 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,566
- Total Day Supply
- 42,521
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $33K
- Generic Drug Cost
- $24K
- Opioid Claims
- 29 (2.7% rate)
- Antibiotic Claims
- 71
Patient Demographics
- Average Patient Age
- 67.3 years
- Avg HCC Risk Score
- 3.41
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 73, 65-74: 81, 75-84: 49, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MUAD MAYA, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Furosemide
Furosemide
136 claims
- Calcium Acetate
Calcium Acetate
67 claims
- Spironolactone 48
Spironolactone
48 claims
- Metolazone 46
Metolazone
46 claims
- Allopurinol 41
Allopurinol
41 claims
- Metoprolol Tartrate 41
Metoprolol Tartrate
41 claims
- Amlodipine Besylate 38
Amlodipine Besylate
38 claims
- Hydralazine Hcl 38
Hydralazine Hcl
38 claims
| Drug | Claims |
|---|---|
| Furosemide | 136 |
| Calcium Acetate | 67 |
| Spironolactone | 48 |
| Metolazone | 46 |
| Allopurinol | 41 |
| Metoprolol Tartrate | 41 |
| Amlodipine Besylate | 38 |
| Hydralazine Hcl | 38 |
| Lisinopril | 37 |
| Losartan Potassium | 34 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nephrology Physician Overview
How MUAD MAYA, MD fits within the Nephrology Physician landscape nationally.
MUAD MAYA, MD's 1,072 claims are below the specialty average of 1,454.
Nearby Nephrology Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as MAYA.
Compare Nephrology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is MUAD MAYA, MD's specialty? ▼
How much does MUAD MAYA, MD prescribe under Medicare Part D? ▼
What is MUAD MAYA, MD's Medicare quality score? ▼
Where is MUAD MAYA, MD located? ▼
What is MUAD MAYA, MD's NPI number? ▼
Does MUAD MAYA, MD prescribe more brand-name or generic drugs? ▼
Does MUAD MAYA, MD prescribe opioids? ▼
How many Nephrology Physician providers are there in the US? ▼
What drugs does MUAD MAYA, MD prescribe most often? ▼
Does MUAD MAYA, MD accept Medicare? ▼
How can I verify MUAD MAYA, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology